Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival

Ming Yu Lien, Ti Hao Wang, Ching Yun Hsieh, Ming Hsui Tsai, Chun Hung Hua, Fu Ming Cheng, Wen Hui Chung, Chih Hsin Tang, Jason Chia-Hsun Hsieh^*

^*此作品的通信作者